Key facts
- This page summarizes Jong Joseph Kim's Form 4 filing for INOVIO PHARMACEUTICALS, INC. (INO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Mar 2022, 16:36.
Jong Joseph Kim - 11 Mar 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- INO
- Reported as of
- 11 Mar 2022
- Net transaction value
- -$127,828
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2022, 16:36:28 UTC
- Prior SEC filing
- 09 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jong Joseph Kim
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jong Joseph Kim filed Form 4 for INOVIO PHARMACEUTICALS, INC. (INO) on 14 Mar 2022.
Change
- Previous filing in this sequence was filed on 09 Mar 2022.
- Current net transaction value: -$127,828.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +139,387
- Change %
- +11%
- Price
- Shares after
- 1,462,325
- Date
- 11 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
INO
transaction
Common Stock
Tax liability
- Transaction value
- $127,828
- Shares
- -39,698
- Change %
- -2.7%
- Price
- $3.22*
- Shares after
- 1,422,627
- Date
- 11 Mar 2022
- Ownership
- Direct
- Footnotes
- F2
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 816,527
- Date
- 11 Mar 2022
- Ownership
- By Family Limited Partnership
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,563
- Date
- 11 Mar 2022
- Ownership
- By Daughter: EK
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,775
- Date
- 11 Mar 2022
- Ownership
- By Son: JK1
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,975
- Date
- 11 Mar 2022
- Ownership
- By Spouse
INO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,533
- Date
- 11 Mar 2022
- Ownership
- By Son: JK2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -139,387
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 139,386
- Date
- 11 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 139,387
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Footnote F2
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.